Complainant states that it is “one of the biggest global pharmaceutical and healthcare groups”; that it “achieved net sales of USD 50.3 billion, and total net income amounted to USD 11.9 billion and employed 75 883 full‑time equivalent employees as of December 31, 2024”; that “[i]ts medicines reach 296 million people worldwide”; and that it “owns numerous domain names composed of either its trademark NOVARTIS alone, including <novartis.com> (created on 2 April 1996) or in combination with other terms, such as <novartispharma.com> (created on 27 October 1999).”<\/p>\n
The Disputed Domain Name was created on August 25, 2025, and, according to the Complaint, “is being passively held.”<\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings that are pending or decided and that relate to the Disputed Domain Name.<\/p>", "no_response_filed": "
Complainant contends, in relevant part, as follows:<\/p>\n
Paragraph 4(a)(i): Complainant states that the Disputed Domain Name is confusingly similar to the NOVARTIS Trademark because the Disputed Domain Name incorporate the NOVARTIS Trademark in its entirety, and addition of the word “careers” does not prevent a finding of confusing similarity.<\/p>\n
Paragraph 4(a)(ii): Complainant states that Respondent has no rights or legitimate interests in respect of the Disputed Domain Name because, inter alia<\/em>, “Complainant has never granted the Respondent with any rights to use the NOVARTIS trademark in any form, including in the disputed domain name”; “there is no evidence that the Respondent is known by the dispute domain name or owns any corresponding registered trademarks”; Complainant sent a cease-and-desist letter to Respondent on November 12, 2025, and a reminder on November 24, 2025, giving Respondent “an opportunity to present some compelling arguments that they have rights or legitimate interests in the disputed domain name but have failed to do so.”<\/p>\n Paragraph 4(a)(iii): Complainant states that the Disputed Domain Name was registered and is being used in bad faith because, inter alia<\/em>, “Complainant’s trademark registrations… significantly predate the registration of the disputed domain name… and the Respondent has never been authorized by the Complainant to register the disputed domain name”; “[t]he NOVARTIS trademark is a well-known trademark registered in many countries”; “the Novartis group has a strong presence online”; “previous UDRP Panels have stated that the NOVARTIS trademark is well-known”; and the doctrine of passive holding applies.<\/p>\n No administratively compliant response has been filed.<\/p>",
"rights": " The Complainant has, to the satisfaction of the Panel, shown the Disputed Domain Name is identical or confusingly similar to a trademark or service mark in which the complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
"no_rights_or_legitimate_interests": " The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the Disputed Domain Name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
"bad_faith": " The Complainant has, to the satisfaction of the Panel, shown the Disputed Domain Name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
"procedural_factors": " The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
"decision": "Accepted",
"panelists": [
"Douglas Isenberg"
],
"date_of_panel_decision": "2026-03-02 00:00:00",
"informal_english_translation": " Complainant states that it “owns numerous trademarks NOVARTIS registered in numerous jurisdictions all over the world.” In support thereof, Complainant cites, and provides documentation in support thereof, inter alia, Int’l Reg. No. 663,765 for NOVARTIS (registered July 1, 1996), EU Reg. No. 13,393,641 for NOVARTIS (registered on March 17, 2015) and U.S. Reg. No. 2,336,960 for NOVARTIS (registered on April 4, 2000). These registrations are referred to herein as the “NOVARTIS Trademark.”<\/p>",
"decision_domains": {
"novartiscareers.org": "TRANSFERRED"
},
"panelist": null,
"panellists_text": null
}